title: [Cell and interactive technologies in the treatment of congenital and acquired heart diseases and ischemic heart disease].
authors.forename: L A
authors.initials: LA
authors.lastname: Bokeriia
authors.forename: G P
authors.initials: GP
authors.lastname: Georgiev
authors.forename: E Z
authors.initials: EZ
authors.lastname: Golukhova
authors.forename: M V
authors.initials: MV
authors.lastname: Eremeeva
authors.forename: A I
authors.initials: AI
authors.lastname: Kim
authors.forename: S L
authors.initials: SL
authors.lastname: Kiselev
authors.forename: M A
authors.initials: MA
authors.lastname: Lagar'kova
authors.forename: I P
authors.initials: IP
authors.lastname: Aslanidi
authors.forename: M N
authors.initials: MN
authors.lastname: Vakhromeeva
authors.forename: K V
authors.initials: KV
authors.lastname: Shatalov
mesh_terms: D020811:Biomedical Technology / Q000379:methods*; D002450:Cell Communication / Q000502:physiology*; D015316:Genetic Therapy / Q000379:methods*; D006801:Humans; D017202:Myocardial Ischemia / Q000151:congenital* / Q000601:surgery / Q000628:therapy*; D011300:Preoperative Care; D042461:Vascular Endothelial Growth Factor A / Q000627:therapeutic use
chemical_list: C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A